Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirudh Sivakumar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advanced Healthcare Materials|April 22, 2021
Interfacing Biomaterials with Synthetic T Cell ImmunityFang-Yi Su, Quoc D Mac, Anirudh Sivakumar, et al.
Cell Reports Methods|February 23, 2023
Embracing enzyme promiscuity with activity-based compressed biosensingBrandon Alexander Holt, Hong Seo Lim, Anirudh Sivakumar, et al.
Nature Biomedical Engineering|March 4, 2022
Urinary detection of early responses to checkpoint blockade and of resistance to it via protease-cleaved antibody-conjugated sensorsQuoc D Mac, Anirudh Sivakumar, Hathaichanok Phuengkham, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Programming T cells for Early Cancer Detection with Customized Protease-Activatable ReceptorsHathaichanok Phuengkham, Ying Chen, Anirudh Sivakumar, et al.
Nature Nanotechnology|January 3, 2025
AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunityAnirudh Sivakumar, Hathaichanok Phuengkham, Hitha Rajesh, et al.
Nature Cancer|May 16, 2025
Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigensLena Gamboa, Ali H Zamat, Chloé A Thiveaud, et al.
Nature Catalysis|December 5, 2022
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzymeJohn Blazeck, Christos S Karamitros, Kyle Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2017
Common coding variant in <i>SERPINA1</i> increases the risk for large artery strokeRainer Malik, Therese Dau, Maria Gonik, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advanced Healthcare Materials|April 22, 2021
Interfacing Biomaterials with Synthetic T Cell ImmunityFang-Yi Su, Quoc D Mac, Anirudh Sivakumar, et al.
Cell Reports Methods|February 23, 2023
Embracing enzyme promiscuity with activity-based compressed biosensingBrandon Alexander Holt, Hong Seo Lim, Anirudh Sivakumar, et al.
Nature Biomedical Engineering|March 4, 2022
Urinary detection of early responses to checkpoint blockade and of resistance to it via protease-cleaved antibody-conjugated sensorsQuoc D Mac, Anirudh Sivakumar, Hathaichanok Phuengkham, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Programming T cells for Early Cancer Detection with Customized Protease-Activatable ReceptorsHathaichanok Phuengkham, Ying Chen, Anirudh Sivakumar, et al.
Nature Nanotechnology|January 3, 2025
AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunityAnirudh Sivakumar, Hathaichanok Phuengkham, Hitha Rajesh, et al.
Nature Cancer|May 16, 2025
Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigensLena Gamboa, Ali H Zamat, Chloé A Thiveaud, et al.
Nature Catalysis|December 5, 2022
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzymeJohn Blazeck, Christos S Karamitros, Kyle Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2017
Common coding variant in <i>SERPINA1</i> increases the risk for large artery strokeRainer Malik, Therese Dau, Maria Gonik, et al.
Pageof 1